Impact of wellness coaching and monitoring services provided in a community pharmacy

Journal of the American Pharmacists Association

Volumn 53, Issue 1, 2013, Pages 14-21

  DiDonato, Kristen L ^a   May, Justin R ^b   Lindsey, Cameron C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Red Cross Pharmacy   (United States)

Author keywords

Community pharmacy; Health coaching; Lifestyle modification; Worksite wellness

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMUNITY CARE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICES RESEARCH; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PATIENT; PHARMACIST; PHARMACY; PRESSURE; QUALITY OF LIFE; SATISFACTION; SCREENING; SHORT FORM 36; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WELLBEING; WORKPLACE;

EID: 84890016000     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.11227     Document Type: Article

References (35)

1. Anderson G. Chronic care: making the case for ongoing care. www.rwjf.org/content/rwjf/en/research-publications/find-rwjf-research/2010/01/ chronic-care.html. Accessed January 6, 2012.
2. Heron MP, Hoyert DL, Murphy SL, Kung HC. Deaths: final data for 2006. Natl Vital Stat Rep. 2006;54(13):1-120.
3. World Health Organization. Preventing chronic diseases: a vital investment. www.who.int/chp/chronic-disease-report/full-report.pdf. Accessed October 22, 2011.
4. Department of Health & Human Services. Healthy People: the surgeon general's report on health promotion and disease prevention. http://profiles.nlm.nih.gov/NN/B/B/G/K/-/nnbbgk.pdf. Accessed October 22, 2011.
5. HealthyPeople.gov. Healthy People 2020 framework. www.healthypeople.gov/ 2020/Consortium/HP2020Framework.pdf. Accessed October 22, 2011.
6. Carnethon M, Whitsel LP, Franklin BA, et al. Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association. Circulation. 2009;120(17):1725-41.
7. Woolf SH. A closer look at the economic argument for disease prevention. JAMA. 2009;301(5):536-8.
8. Hoerger TJ, Hicks KA, Sorensen SW, et al. Cost-effectiveness of screening for pre-diabetes among overweight and obese US adults. Diabetes Care. 2007;30(11):2874-9.
9. Linden A, Butterworth SW, Prochaska JO. Motivational interviewing-based health coaching as a chronic care intervention. J Eval Clin Pract. 2010;16(1):166-74.
10. Funnell MM. Helping patients take charge of their chronic illnesses. Fam Pract Manag. 2000;7(3):47-51.
11. Huffman M. Health coaching: a new and exciting technique to enhance patient self-management and improve outcomes. Home Healthc Nurse. 2007;25(4):271-4.
12. Wolever RQ, Dreusicke M, Fikkan J, et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ. 2010;36(4):629-39.
13. Huffman MH. Health coaching: a fresh approach for improving health outcomes and reducing costs. AAOHN J. 2010;58(6):245-50.
14. Dhoot A, Rutter PM. The provision of diagnostic and screening services by community pharmacies. Int J Pharm Pract. 2002;10(suppl):R51.
15. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc. 2000;40(6):773-9.
16. Madejski RM, Madejski TJ. Cholesterol screening in a community pharmacy. J Am Pharm Assoc. 1996;NS36(4):243-8.
17. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40(2):157-65.
18. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):149-59.
19. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173-84.
20. Cranor CW, Christensen DB. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):160-72.
21. Garrett DG, Martin LA. The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc. 2003;43(2):185-90.
22. Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005;45(2):130-7.
23. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133-47.
24. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23-31.
25. Fera T, Bluml BM, Ellis WM, et al. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc. 2008;48(2):181-90.
26. Fera T, Bluml BM, Ellis WM. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383-91.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
28. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
29. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-61.
30. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Publ. no. 98-4083. Bethesda, MD: National Institutes of Health; 1998.
31. Ware JE, Kosinski M. SF-36 physical and mental health summary scales: a manual for users of version 1. 2nd ed. Lincoln, RI: QualityMetric; 2001.
32. McDonough, RP. Using relationship marketing to expand pharmacy services: the dynamics of pharmaceutical care: enriching patients' health. Washington, DC: American Pharmacists Association; 2007.
33. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
34. Baker RC, Kirschenbaum DS. Self-monitoring may be necessary for successful weight control. Behav Ther. 1993;24(3):377-94.
35. Lichtman SW, Pisarska K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med. 1992;327(27):1893-8.